SMYD3 and metastatic neoplasm: Further stratification of TCGA-COAD cases showed that tumors with distant metastasis (M1, n = 52) exhibited markedly higher SMYD3 expression than both non-metastatic tumors (M0, n = 333) and normal controls (n = 820) (Figure 1C).